Presented at the 5th International Symposium on Mushroom Nutrition, University of Westminster, June 14th, 2002.
This study of increasing Coriolus versicolor supplementation (4.5 grams per day to 13.0 grams per day over a 90 day period) measures the impact of such supplementation on telomerase activity, interleukin 5, interleukin 12 and Tumour Necrosis Factor Beta over 120 days. Results were a significant decrease in teleomerase and interleukin-12 activity, followed by a significant increase in interleukin-5 activity within 120 days.
To contact Dr. Julian Kenyon (MD MB ChB)
Dove Clinic for Integrated Medicine
97 Harley Street
London W1G 6AG
United Kingdom
Tel:44-207-487-4442
Email: doveclinic@ukonline.co.uk
http://www.doveclinic.com
Clinical Articles
The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.
Download PDF
Clinical articles
-
Hericium erinaceus and Coriolus versicolor Modulate Molecular and Biochemical Changes after Traumatic Brain Injury
Ramona D’Amico 1,†, Angela Trovato Salinaro 2,†, Roberta Fusco 1,†, Marika Cordaro 3, Daniela Impellizzeri 1, Maria Scuto 2, Maria Laura Ontario 2, Gianluigi Lo Dico 2, Salvatore Cuzzocrea 1,4,*, Rosanna Di Paola 1,*, Rosalba Siracusa 1,‡ and Vittorio Calabrese 2,‡ -
Hericium Erinaceus Prevents DEHP-Induced Mitochondrial Dysfunction and Apoptosis in PC12 Cells
Ines Amara (1)(2), Maria Scuto (2), Agata Zappalà (2), Maria Laura Ontario (2), Antonio Petralia (3), Alwa Abid -Essefi (1), Luigi Maiolino (3), Anna Signorile (4), Angela Trovato Salinaro (2) and Vittorio Calabrese (2). -
Effect of combined therapy polyhexamethylene biguanide and Coriolus-MRL on human papilloma virus (HPV) cervical and vulvar-related lesions
D. Gincheva(1), V. Gincheva(2), E. Konova(1)
-
Nutritional Mushroom Treatment in Meniere’s Disease with Coriolus versicolor: A Rationale for Therapeutic Intervention in Neuroinflammation and Antineurodegeneration
Maria Scuto (1),y , Paola Di Mauro (2),y, Maria Laura Ontario (1), Chiara Amato (2), Sergio Moda_eri (1), Domenico Ciavardelli (3,4), Angela Trovato Salinaro (1), Luigi Maiolino (2),* and Vittorio Calabrese (2)